Trials / Completed
CompletedNCT05948527
Safety and Efficacy of High Flow Nasal Canula in Patients With Mild Hypercapnia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate safety and efficacy of application ( high flow nasal canula) in cases with mild hypercapnia, included 30 patients who were hospitalized in Mansoura University chest department with mild Hypercapnia (Pco2 range 45-60 mmhg and power of hydrogen not less 7.30) of different pulmonary disease categories (Chronic obstructive pulmonary disease acute exacerbation, pneumonia, Interstitial lung diseases, etc).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | high flow nasal canula | administration of high flow nasal canula at initial flow 35 liters per minute and Fio2 (fraction of inspired oxygen of 50%) with titration to reach oxygen saturation of 88-92%. |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-07-01
- Completion
- 2023-07-01
- First posted
- 2023-07-17
- Last updated
- 2023-07-17
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05948527. Inclusion in this directory is not an endorsement.